3 patents
Utility
Methods and Compositions for Identifiying a Survivability Index for an Animal
13 Apr 23
The present invention provides a method of identifying and mitigating a risk of deathloss of an animal, comprising receiving, at a processor from a hematology analyzer, information obtained from a sample from said animal, wherein said information comprises a leukocyte absolute count and a leukocyte differential from said sample, said sample comprising leukocytes, analyzing, by said processor, said leukocyte absolute count and said leukocyte differential to determine a survivability index for said animal, and managing the animal based on the survivability index.
Rodolfo R. Rodriguez, Brian Pike, Ada Tsoi, Stefano Bresolin, Jasper N. Pollard, Joy Parr Drach, Mitchell Hockett, Norah Gerow Bate, Danielle Stewart Noel, Felipe Guirado Dantas
Filed: 25 Feb 21
Utility
Rapid Mobile Screening and Triage for Infections and Infection Severity
30 Mar 23
A method of analyzing a blood sample from a subject includes loading the blood sample into a single chamber; acquiring, via an imaging system, a stack of serial focal plane images of the blood sample from a plurality of fields of view of the chamber; creating a virtual three dimensional image of the blood sample from selected ones of the stacks of serial focal plane images; and analyzing the virtual three dimensional image to identify blood formed elements within the blood sample.
Joy Parr Drach, Brendan Smith, Tobias M. Heineck, Stefano Bresolin, Rodolfo R. Rodriguez, Danielle Stewart Noel, Brian Pike, Oleg Kakhovsky, Jasper N. Pollard
Filed: 12 Mar 21
Utility
5xs22vcgp3ih8w2tmcs19gkbgeotdtnia57gd6wxwkuol297nzg9py49w
2 Sep 21
The present invention provides a method of identifying an animal for which antibiotic treatment, anti-infective treatment, probiotic treatment, immunostimulant treatment, additional monitoring and/or a separate or alternative management strategy is appropriate, comprising: a) collecting a sample from said animal; b) performing a leukocyte differential cell count on said sample; c) comparing said leukocyte differential cell count of (b) with an index of infection; and d) initiating antibiotic treatment, anti-infective treatment, probiotic treatment, immunostimulant treatment, additional monitoring and/or a separate or alternative management strategy of said animal on the basis of said comparing step.
Joy Parr Drach, Mitchell Hockett, Stefano Bresolin, Erik J. Jensen, Tobias M. Heineck, Jasper N. Pollard, Deborah Asion, Rodolfo R. Rodriguez, David A. Calderwood, Norah Gerow Bate, John Richard Sink, Jorge Carlos Correa
Filed: 12 Feb 21
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first